CNR1 and type 2 diabetes mellitus: Applying CB1R antagonists or inverse agonists as adjuvant therapy to lifestyle modulation by weight reduction, exercise, and glycemic and lipemic control in obese and T2D patients seems to be beneficial [15,33,52].